Sanjay Shukla
Fortune : 91 671 $ au 30/06/2026
Fortune : 91 671 $ au 30/06/2026
Sanjay S.
Shukla is currently President, Chief Executive Officer & Director at aTyr Pharma, Inc. since 2017.
Formerly, Dr. Shukla was Chief Executive Officer at Rxmd, Inc. from 2009 to 2012 and Vice President & Head-Integrated Medical Services at Novartis AG from 2012 to 2015.
Education includes undergraduate and graduate degrees from the University of Maryland in 1994 and 1995, respectively, and a doctorate from Howard University College of Medicine in 2001.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ATYR PHARMA, INC. 0,16 % | 01/03/2026 | 153 553 ( 0,16 % ) | 91 671 $ | 30/06/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| ATYR PHARMA, INC. | Directeur Général | 01/11/2017 |
| Sociétés | Poste | Fin |
|---|---|---|
| NOVARTIS AG | Corporate Officer/Principal | 01/04/2015 |
Rxmd, Inc. | Directeur Général | 01/09/2012 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 5 |
|---|---|
aTyr Pharma, Inc.
aTyr Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a bio therapeutics company that discovers and develops medicines based on novel biological pathways | Health Technology |
Novartis AG
Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
University of Maryland
University of Maryland Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Howard University College of Medicine
Howard University College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rxmd, Inc. |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national